Accessibility     Accessibility |
My DCU | Library | Loop |

☰       Department Menu


 DCU SmartStadium nominated for US-Ireland Research Innovation Awards

DCU SmartStadium nominated for US-Ireland Research Innovation Awards

DCU Insight, Intel and Microsoft have been shortlisted for the US-Ireland Research Innovation Awards for artificial intelligence research, concentrating on computer vision methods to ensure crowd safety as demonstrated in the “Smart Croke Park” test-bed.

Now in their fourth year, the awards recognise excellence in research innovation, creation and invention by an organisation, as a result of US foreign direct investment (FDI) in Ireland.  The winners will be announced on 18 May at the Chamber’s Annual Dinner in the presence of Minister for Business, Enterprise and Innovation, Heather Humphreys.

There are three categories: Irish operations of a US multinational company; higher education institution research centres or institutes; and Irish SMEs with with a link to the US corporate sector. The Awards are a collaboration between the American Chamber of Commerce Ireland and the Royal Irish Academy. They are generously supported by KPMG and Ulster Bank with media partner The Irish Times.

Other shortlisted candidates are as follows:

  • Science Foundation Ireland CONNECT and Google for ViSQOL, a software platform for evaluating audio quality on the web by "looking" at sounds. It can predict sound quality in a wide range of internet scenarios from streaming music and video conferencing to virtual reality 3D spatial audio.
  • Xilinx Ireland for a successfully designed software defined radio microchip (RFSOC) in 16nm FinFET technology, an industry first to address the emerging cost, power, size and flexibility requirements in emerging 5G cellular networks.
  • DePuy Synthes Innovation Centre in Cork Ireland working with US colleagues & AMBER created a step change improvement in process technologies for manufacturing orthopaedic implants with osteointegration coatings to better serve patients receiving their products.
  • Abbott Vascular Clonmel for XIENCE Sierra, a drug eluting stent, now CE Marked, researched and developed collaboratively between colleagues in Clonmel and California Alltech European Bioscience Centre for research on how reduced diversity among intestinal gut microbes can affect health, lead to overgrowth of pathogens and development of resistance. By increasing gut microbial diversity through nutrition and diet, control of these issues can be increased with the aim of reducing reliance on antibiotics
  • Oxymem Ltd for collaboration with Dow Water and Process solutions.
  • Orreco for building the world’s first AI coach for elite athletes and health-conscious consumers. Blending novel sports and data science with IBM Watson, Orreco analyses blood biomarkers, training and wellness data to reduce injury and illness and to optimise performance.

2nd March, 2018